However, the anti-SIRPα antibody alone neither inhibited tumour growth (P>0.05, Fig. 4E) nor prolonged the survival time of tumour-bearing mice (P>0.05, Fig. 4F). The gene discussed is SIRPA; the disease is neoplasm.